Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Peter Kazimir, governor of Slovakia's central bank and an ECB policymaker, said on Monday that only a sizeable departure from the ECB's baseline economic and inflation outlook would justify a change to the current monetary policy stance. He reiterated that inflation risks are balanced but conditional on favorable energy prices, and warned that unce…
RBC Capital has raised its price target on Flowserve Corp. to $96 from $83 and retained an Outperform rating after the company's fourth-quarter 2025 operational outperformance and upbeat guidance for 2026. The firm highlighted ambitious 2030 margin targets, a $490 million acquisition of Trillium, and solid growth across power/nuclear, energy and ge…
Bernstein SocGen Group trimmed its price target on HubSpot Inc to $448 from $602 while retaining an Outperform rating ahead of the company's Q4 2025 results. The move comes amid a sharp pullback in the stock over the past month and year, continued AI-related uncertainty across software vendors, and a recalibration of software sector multiples. Othe…
William Blair reaffirmed an Outperform rating on Northern Oil and Gas (NYSE: NOG), projecting stable fourth-quarter 2025 results and a 2026 production ramp tied to higher early-year capital spending. The company’s recent Ohio Utica Shale acquisition, larger hedging positions and a 7% dividend yield factor into analyst views even as several firms cu…
Truist Securities has reiterated its Buy rating on Vail Resorts (MTN) and kept a $234.00 price target after a meeting with the company’s chief financial officer in Vail, Colorado. The target implies roughly 69% upside from the stock’s current price of $137.99. Truist and other brokers weighed improving commercial tactics and pass-sale momentum agai…
RBC Capital has increased its 12-month price target for nVent Electric (NVT) to $138 from $136 while retaining an Outperform rating. The new target implies roughly a 19.7% upside from the current share price of $115.31. RBC points to robust datacenter-related demand, a large and growing backlog and accelerating organic revenue as the primary driver…
Wolfe Research upgraded Cushman & Wakefield (NYSE: CWK) from Peerperform to Outperform, assigning a $19.00 price target that implies roughly an 18% total return to year-end 2026. The firm cites what it views as an attractive valuation and growth profile, noting the stock's low PEG ratio and an apparent gap between historical pricing and forward exp…
BTIG has reaffirmed a Buy rating on Dynatrace Inc. (DT) and set a $67 price target, pointing to artificial intelligence as a catalyst for the company’s core Application Performance Monitoring business. The target implies roughly an 87% increase from the stock’s cited level, while recent analyst moves and the company’s upcoming quarterly report fram…
Safe Harbor Financial's shares climbed after the Denver-based cannabis fintech platform reached an amended commercial agreement with Partner Colorado Credit Union that extends the partnership through December 2031, increases interest income participation to as much as 65%, and is expected to produce $9 million in additional revenue over the life of…
Amazon fell into a broad AI-capex panic despite AWS showing healthy monetization and high margins. The stock is oversold (RSI ~27), trading well below its moving averages, and the pullback offers a controlled, asymmetric trade with a mid-term horizon. Entry at $205.65, stop at $195.00, target $255.00.
Merck (MRK) is a pragmatic buy into 2026. The stock trades at roughly a mid-teens P/E, produces strong free cash flow ($13.05B), and still benefits from Keytruda momentum and an expanding animal health business. Near-term guidance that missed Street estimates and binary clinical readouts create a time-sensitive window—the fundamentals argue for acc…
Stellantis will record a €22.2 billion charge tied to a downsizing of its electric-vehicle plans, with the costs booked in the second half of 2025. Wolfe Research upgraded the stock to Peer perform from Underperform after a roughly 25% decline, calling the writedown a reset point and pointing to potential sequential improvement in 2026-27, though i…
Truist Securities has kept a Buy rating on Uber Inc. with a $108 price target following Uber’s announced acquisition of Getir’s delivery portfolio in Türkiye. The move, together with an earlier purchase of Trendyol Go, is expected to lift gross bookings for Uber’s Delivery segment in Turkey over coming years and to contribute to growth beginning in…
Bernstein has reaffirmed an Outperform rating and a $95.00 price target on Zillow Group (ZG) following a favorable ruling tied to the company’s dispute with Compass. The decision, which allows Zillow to continue applying its listing rules, arrives just ahead of the company’s Feb. 10 earnings report and comes amid mixed analyst positioning and recen…
Truist Securities has kept a Buy rating and a $140 price target on Encompass Health Corp (EHC) after the company reported fourth-quarter results that beat several expectations. The target implies roughly 31% upside from the stock’s recent price, and the report highlights durable cash flow, expanding margins and constructive regulatory commentary as…
RBC Capital lowered its price target on Datadog to $150 from $175 but retained an Outperform rating. The move, taken ahead of the company's February earnings report and analyst day, reflects peer-multiple compression even as Datadog trades at a high P/E and posts strong gross margins. Other brokers have also adjusted targets amid mixed views on 202…
Piper Sandler has reaffirmed an Overweight rating and a $51.00 price target on Edgewise Therapeutics (NASDAQ:EWTX) ahead of pivotal clinical readouts scheduled in 2026. The broker highlighted the company’s EDG-7500 program for hypertrophic cardiomyopathy and a second-generation HFpEF asset, while analysts show a bullish consensus on the stock.
Truist Securities has affirmed a Hold rating and a $48.00 price target on Advance Auto Parts (AAP) ahead of the company’s impending quarterly report, while noting modest comparable-sales growth expectations and expressing low confidence in midterm operating margin projections. The stock has outperformed Truist’s target amid strong recent gains, and…
Piper Sandler has maintained its Overweight rating and $57.00 price target on Fifth Third Bancorp (FITB) after a series of meetings between the bank’s senior management and institutional investors. Management framed integration of the recently completed CMA transaction as the top priority, outlined constructive loan growth expectations and signaled…
Veeva Systems is deep in oversold territory after a sharp pullback. Strong free cash flow, a fresh $2 billion buyback, and an expanding addressable market for regulated cloud workflows argue for a mean-reversion trade. This idea lays out a precise entry, stop and target with rationale and risks.
Playboy's stock jumped 26% after the company agreed to sell a 50% stake in its China operations to United Trademark Group for a package of cash payments totaling $122 million. The transaction transfers operational control in China, Hong Kong and Macau to UTG, includes guaranteed distributions and brand support funding, and is designed to be immedia…
Deputy Prime Minister David Lammy and housing minister Steve Reed publicly affirmed their support for Prime Minister Keir Starmer on Monday, responding to a call for his resignation from Scottish Labour leader Anas Sarwar amid pressure linked to the Mandelson-Epstein scandal. Lammy and Reed urged continuity, stressing the need to remain focused on …
SeaStar Medical Holding Corporation (NASDAQ:ICU) shares declined 4.8% after the company published early post-approval clinical experience for its QUELIMMUNE therapy in pediatric patients. Results from the first 21 children in the SAVE Registry reported no device-related adverse events, with survival rates of 76% at Day 28 and Day 60, and 71% at Day…
Kevin Hassett, director of the National Economic Council, told viewers that Americans should expect somewhat smaller monthly job creation figures in the months ahead. He attributed the anticipated decline to slowing population growth combined with accelerating productivity, and emphasized that such a pattern does not indicate overall economic weakn…
Clearmind Medicine Inc (NASDAQ:CMND) shares fell 6.6% on Monday after the company published safety findings from six additional patients in the second cohort of its Phase I/IIa study of CMND-100 for Alcohol Use Disorder. The data showed no serious adverse events and tolerability consistent with the first cohort, while investors appeared to react ne…
